Basic Responsive HTML5
  • About
    • Corporate Overview
    • Founders
    • Management
    • Scientific Advisory Board
    • Board of Directors
    • Board of Advisors
    • Partnerships
  • Videos
    • ACP Testimonials
    • CEO Updates
    • News
  • Technology
    • Technology Overview
    • Manufacturing
    • Intellectual Property
    • Publications
  • Clinical Pipeline
    • ACP-01 Phase II Clinical Trial for CLI
    • CLI Phase II Trial Summary
    • Platform
    • Critical Limb Ischemia
  • Investors
    • Investor Overview
    • Analysts
    • A Three Minute Summary
    • Public Filings
    • AGM Materials
  • News & Media
    • News / Press Releases
  • Contact
MENU ≡
  • About
    • Corporate Overview
    • Founders
    • Management
    • Scientific Advisory Board
    • Board of Directors
    • Board of Advisors
    • Partnerships
  • Videos
    • ACP Testimonials
    • CEO Updates
    • News
  • Technology
    • Technology Overview
    • Manufacturing
    • Intellectual Property
    • Publications
  • Clinical Pipeline
    • ACP-01 Phase II Clinical Trial for CLI
    • CLI Phase II Trial Summary
    • Platform
    • Critical Limb Ischemia
  • Investors
    • Investor Overview
    • Analysts
    • A Three Minute Summary
    • Public Filings
    • AGM Materials
  • News & Media
    • News / Press Releases
  • Contact

News & Media

  • all
  • 2021
  • 2020
  • 2019
  • 2018
  • 2017
  • 2016
  • 2015
  • 2014

Nov 26 / 2014

Hemostemix and Technical Ventures Complete RTO Transaction
Oct 02 / 2014

Theravitae Inc. Announces Leadership Transition
Jun 25 / 2014

Hemostemix Advances Clinical Trial Preparation
May 05 / 2014

Hemostemix Joins Centre for Commercialization of Regenerative Medicine, Industry Consortium
Apr 22 / 2014

Hemostemix Announces its Second US Patent

  • Contact
  • Safe Harbour

Copyright © 2021 Hemostemix Inc. All rights reserved.